This means that Indian travellers visiting Saudi Arabia will not have to serve the mandatory quarantine, a move which is expected to boost tourism in the country
The Kingdom of Saudi Arabia has approved and recognised the Covishield vaccine, produced by the Serum Institute of India (SII) for international travellers visiting the country. The vaccine that is in wide use in India has now become the 9th vaccine approved by the Kingdom approved for entering its borders. This also means that Indian travellers visiting Saudi Arabia will not have to serve the mandatory quarantine, a move which is expected to boost tourism in the country.
The approval of Covishield is a welcome move as Saudi Arabia readies to welcome Indian tourists. Saudi Arabia first opened to international leisure tourists in September 2019, with the launch of the tourism visa.
There is no official word yet on the approval of Covaxin, which has recently received recognition from the WHO
Indian travellers, who have spent 14 days in a country that is not on the list of countries where entry is temporarily suspended immediately before entering Saudi Arabia, are also permitted as long as they are fully immunised. A negative RT-PCR test not older than 72 hours before is mandatory to present before departure for everyone.
There is no official word yet on the approval of Covaxin, which has recently received recognition from the World Health Organisation (WHO). Apart from Covishield, Pfizer, Comirnaty, Oxford AstraZeneca, SK Bioscience, Vaxzevria. Moderna. Spikevax and Johnson & Johnson are the vaccines approved by the Saudi authorities.
************************************************************************
Readers